R. Kumar, S. K. Singh, S. Singh, and A. Kumar, “Addressing cardio-metabolic risks in type 2 diabetes: evidence-based insights on efpeglenatide”, Int J Basic Clin Pharmacol, vol. 14, no. 4, pp. 565–582, Jun. 2025.